Early studies suggest it might have some health benefits, but it's not clear exactly how it works
The science of Microdosing GLP-1 Broad clinical potential: Commonly used to treat type 2 diabetes and weight management, GLP-1 medications act on GLP-1 receptors located in the brain, gut, and immune system, impacting multiple biomarkers. Recent studies have begun exploring low doses of GLP-1 medications for broader health goals beyond glucose control and weight loss. Emerging research in healthspan and longevity: In a series of studies, low doses of GLP-1 receptor agonists were shown to modulate inflammatory pathways, support mitochondrial function, and lower the risk of cognitive decline in study participantsgiving Microdosing GLP-1 promising potential for extending healthspan
This has led to several researches advocating the use of either glutathione itself [3, 5] or N-acetylcysteine [6] as a treatment for COVID-19 patients
(Glutathione) (Antioxidant) (Free Radical)
True excellence in research requires thinking about the bigger picture
151,152 As sensitive DNA damage sensors, PAPRs are recruited and immediately activated by DNA breaks